Asthma development is associated with low mucosal IL ‐10 during viral infections in early life
Allergy · 2024
DOI: 10.1111/all.16276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Mathias Elsner Melgaard und 12 weiteren Autor:innen. Beteiligte Einrichtung: COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Asthma, Virus Diseases, Interleukin-10. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Novo Nordisk Fonden, Herlev-Gentofte Hospital's local foundation, The Children's Lung foundation.
Abstract (Originalsprache)
Background
Viral infection is a common trigger of severe respiratory illnesses in early life and a risk factor for later asthma development. The mechanism leading to asthma could involve an aberrant airway immune response to viral infections, but this has rarely been studied in a human setting.
Objectives
To investigate in situ virus‐specific differences in upper airway immune mediator levels during viral episodes of respiratory illnesses and the association with later asthma.
Methods
We included 493 episodes of acute respiratory illnesses in 277 children aged 0–3 years from the COPSAC 2010 mother–child cohort. Levels of 18 different immune mediators were assessed in nasal epithelial lining fluid using high‐sensitivity MesoScale Discovery kits and compared between children with and without viral PCR‐identification in nasopharyngeal samples. Finally, we investigated whether the virus‐specific immune response was associated with asthma by age 6 years.
Results
Viral detection were associated with upregulation of several Type 1 and regulatory immune mediators, including IFN‐ɣ, TNF‐α, CCL4, CXCL10 and IL‐10 and downregulation of Type 2 and Type 17 immune mediators, including CCL13, and CXCL8 (FDR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, Kgs. Lyngby, Denmark.
- Department of Pediatrics, Slagelse Sygehus, Slagelse, Denmark.
- Department of Pediatrics and Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
- Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs. Lyngby, Denmark.
- Department of Food Science, University of Copenhagen, Frederiksberg C, Denmark.
ORCID-Profile: Mathias Elsner Melgaard, Signe Kjeldgaard Jensen, Ann-Marie Malby Schoos, James Gern, Jakob Stokholm
Förderung
- Novo Nordisk Fonden
- Herlev-Gentofte Hospital's local foundation
- The Children's Lung foundation
- Region Hovedstaden
- Strategiske Forskningsraring;d
- The Danish Ministry of Health
- Lundbeck Foundation
- Strategiske Forskningsråd
Zitieren
APA
Melgaard, M. E., Jensen, S. K., Eliasen, A., Pedersen, C. T., Thorsen, J., Mikkelsen, M., Vahman, N., Schoos, A. M., Gern, J., Brix, S., Stokholm, J., Chawes, B. L., & Bønnelykke, K. (2024). Asthma development is associated with low mucosal IL ‐10 during viral infections in early life. Allergy. https://doi.org/10.1111/all.16276
Vancouver
Melgaard ME, Jensen SK, Eliasen A, Pedersen CT, Thorsen J, Mikkelsen M, et al. Asthma development is associated with low mucosal IL ‐10 during viral infections in early life. Allergy. 2024. doi:10.1111/all.16276
BibTeX
@article{Melgaard2024,
author = {Melgaard, Mathias Elsner and Jensen, Signe Kjeldgaard and Eliasen, Anders and Pedersen, Casper-Emil Tingskov and Thorsen, Jonathan and Mikkelsen, Marianne and Vahman, Nilofar and Schoos, Ann-Marie Malby and Gern, James and Brix, Susanne and Stokholm, Jakob and Chawes, Bo Lund and Bønnelykke, Klaus},
title = {Asthma development is associated with low mucosal IL ‐10 during viral infections in early life},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16276}
}
EUVIMED